Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Average R

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Average Recommendation of "Hold" from Analysts

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have earned an average recommendation of “Hold” from the three analysts that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation. The average 1 year price target among brokers that have updated their coverage on the […]

Related Keywords

United States , Pascal Touchon , Anhco Nguyen , Atara Biotherapeutics Inc , Pricet Rowe Associates Inc , Nasdaq , Staley Capital Advisers Inc , Capital Management , Securities Exchange Commission , Redmile Group , Acadian Asset Management , Get Free Report , Marketbeat Ratings , Exchange Commission , Asset Management , Staley Capital Advisers , Capital Advisers , Get Free ,

© 2025 Vimarsana